Inspired: Smartphone Videogame-Based Smoking Cessation Intervention
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03929003 |
Recruitment Status :
Completed
First Posted : April 26, 2019
Last Update Posted : March 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Smoking Cessation | Behavioral: Inspired | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 48 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Two group randomization |
Masking: | Single (Participant) |
Masking Description: | Participants will not be told whether they are in the control or experimental group. |
Primary Purpose: | Treatment |
Official Title: | Breathe Free: Smartphone Videogame-Based Incentives for Smoking Cessation |
Actual Study Start Date : | April 5, 2019 |
Actual Primary Completion Date : | January 1, 2020 |
Actual Study Completion Date : | January 20, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Contingent
Participants in this arm will be required to meet CO goals in order to earn game-based rewards.
|
Behavioral: Inspired
The investigators will be studying the ability of using videogame-based rewards to increase smoking abstinence when they are made contingent on meeting abstinence goals. |
Active Comparator: Non-contingent
Participants in this arm will submit CO verifications but will earn game-based rewards independent of meeting CO goals.
|
Behavioral: Inspired
The investigators will be studying the ability of using videogame-based rewards to increase smoking abstinence when they are made contingent on meeting abstinence goals. |
- Smoking abstinence [ Time Frame: 7 days ]self-report of smoking abstinence over the previous 7-day period.
- Demographic [ Time Frame: 7 weeks ]description of participants

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Inclusionary criteria: Participants will be required to be of legal smoking age (>19 in Alabama, Alaska, New Jersey, Utah, and in Onondaga, Nassau and Suffolk Counties in New York, > 18 years of age in the remainder of the United States). Participants must also report smoking >10 cigarettes per day, report smoking for >2 years, answer 8 or higher on a Likert scale asking how much the person wishes to quit smoking right now (1 = not at all, 10 =very much), have a smartphone with a data plan and active contract extending for at least two months from the enrollment date (i.e., the duration of the study), and reside in the U.S. Participants in the study must submit an initial CO reading > 10ppm (to prevent nonsmokers from enrolling in the study), Literacy will be assessed by having the participant read the first few lines of the consent form out loud, and will be an inclusion criterion because elements of "Breathe Free" will require reading.
Exclusion Criteria:
- Individuals will be excluded from the study if they report smoking any combustible products >2 times per month, report unstable medical/psychiatric conditions that might interfere with the study objectives (e.g., asthma), report living with someone who smokes in the house, or has a career that results in excessive exposure to CO. All excluded participants will be emailed the following smoking cessation information: the "Clearing the Air" packet developed by the National Cancer Institute, Smokefree.gov, Quitsmokinghelpline.com, and the National Academies Press "Dying to quit."

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03929003
United States, New Jersey | |
Rowan University | |
Glassboro, New Jersey, United States, 08028 |
Responsible Party: | Rowan University |
ClinicalTrials.gov Identifier: | NCT03929003 |
Other Study ID Numbers: |
ProG0520140170 |
First Posted: | April 26, 2019 Key Record Dates |
Last Update Posted: | March 10, 2020 |
Last Verified: | March 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |